Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 7.96% |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | -12.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.54% |
| Mar 31, 2026 | -15.80% |
| Dec 31, 2025 | -16.57% |
| Sep 30, 2025 | -17.32% |
| Jun 30, 2025 | -15.25% |
| Mar 31, 2025 | -11.28% |
| Dec 31, 2024 | -2.09% |
| Jun 30, 2024 | 11.77% |
| Mar 31, 2024 | 15.49% |
| Dec 31, 2023 | 13.53% |
| Sep 30, 2023 | 14.94% |
| Jun 30, 2023 | 13.28% |
| Mar 31, 2023 | 11.98% |
| Dec 31, 2022 | 11.41% |
| Sep 30, 2022 | 7.39% |
| Jun 30, 2022 | 4.30% |
| Mar 31, 2022 | 1.85% |
| Dec 31, 2021 | -1.56% |
| Jun 30, 2021 | -11.53% |
| Mar 31, 2021 | -12.96% |